Search

Peter Paras Jr.

Supervisory Patent Examiner (ID: 10504, Phone: (571)272-4517 , Office: P/1632 )

Most Active Art Unit
1632
Art Unit(s)
1632, 1635
Total Applications
422
Issued Applications
86
Pending Applications
232
Abandoned Applications
108

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17733384 [patent_doc_number] => 20220218843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-14 [patent_title] => NON-DISRUPTIVE GENE THERAPY FOR THE TREATMENT OF MMA [patent_app_type] => utility [patent_app_number] => 17/267482 [patent_app_country] => US [patent_app_date] => 2018-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15417 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17267482 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/267482
NON-DISRUPTIVE GENE THERAPY FOR THE TREATMENT OF MMA Oct 29, 2018 Abandoned
Array ( [id] => 13982485 [patent_doc_number] => 20190060400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-28 [patent_title] => USE OF DESIGNER RECEPTORS EXCLUSIVELY ACTIVATED BY DESIGNER DRUGS AND ULTRASOUND IN THE TREATMENT OF SEIZURE DISORDERS [patent_app_type] => utility [patent_app_number] => 15/921906 [patent_app_country] => US [patent_app_date] => 2018-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18527 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15921906 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/921906
USE OF DESIGNER RECEPTORS EXCLUSIVELY ACTIVATED BY DESIGNER DRUGS AND ULTRASOUND IN THE TREATMENT OF SEIZURE DISORDERS Mar 14, 2018 Abandoned
Array ( [id] => 16808232 [patent_doc_number] => 20210130785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => MEDIUM FOR INDUCING DIFFERENTIATION OF STEM CELLS INTO MESODERMAL CELLS AND METHOD FOR PRODUCING MESODERMAL CELLS [patent_app_type] => utility [patent_app_number] => 16/480670 [patent_app_country] => US [patent_app_date] => 2018-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7600 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480670 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/480670
MEDIUM FOR INDUCING DIFFERENTIATION OF STEM CELLS INTO MESODERMAL CELLS AND METHOD FOR PRODUCING MESODERMAL CELLS Jan 24, 2018 Abandoned
Array ( [id] => 17679583 [patent_doc_number] => 11363812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-21 [patent_title] => Cell freezing medium for clinical use [patent_app_type] => utility [patent_app_number] => 16/472962 [patent_app_country] => US [patent_app_date] => 2017-12-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 3844 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16472962 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/472962
Cell freezing medium for clinical use Dec 24, 2017 Issued
Array ( [id] => 16598362 [patent_doc_number] => 20210024893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => MEDICAL USES OF EXOSOMES [patent_app_type] => utility [patent_app_number] => 16/341793 [patent_app_country] => US [patent_app_date] => 2017-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11902 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 204 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16341793 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/341793
MEDICAL USES OF EXOSOMES Oct 11, 2017 Abandoned
Array ( [id] => 14338769 [patent_doc_number] => 20190151357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-23 [patent_title] => MATERIALS AND METHODS FOR PRODUCING AND USING MITOCHONDRIAL PREPARATIONS [patent_app_type] => utility [patent_app_number] => 16/321317 [patent_app_country] => US [patent_app_date] => 2017-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12706 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16321317 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/321317
MATERIALS AND METHODS FOR PRODUCING AND USING MITOCHONDRIAL PREPARATIONS Sep 10, 2017 Abandoned
Array ( [id] => 17695939 [patent_doc_number] => 11369641 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-28 [patent_title] => Identification and uses of vasculature forming progenitor cells and progenitor cell combinations [patent_app_type] => utility [patent_app_number] => 16/323079 [patent_app_country] => US [patent_app_date] => 2017-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 49 [patent_no_of_words] => 13878 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16323079 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/323079
Identification and uses of vasculature forming progenitor cells and progenitor cell combinations Aug 24, 2017 Issued
Array ( [id] => 17200400 [patent_doc_number] => 20210340495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-04 [patent_title] => METHOD FOR INDUCING AND DIFFERENTIATING PLURIPOTENT STEM CELLS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/322640 [patent_app_country] => US [patent_app_date] => 2017-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11812 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322640 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/322640
METHOD FOR INDUCING AND DIFFERENTIATING PLURIPOTENT STEM CELLS AND USES THEREOF Jul 26, 2017 Abandoned
Array ( [id] => 12051500 [patent_doc_number] => 20170327844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-16 [patent_title] => 'OPTIMIZATION OF DETERMINANTS FOR SUCCESSFUL GENETIC CORRECTION OF DISEASES, MEDIATED BY HEMATOPOIETIC STEM CELLS' [patent_app_type] => utility [patent_app_number] => 15/603510 [patent_app_country] => US [patent_app_date] => 2017-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 51600 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15603510 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/603510
OPTIMIZATION OF DETERMINANTS FOR SUCCESSFUL GENETIC CORRECTION OF DISEASES, MEDIATED BY HEMATOPOIETIC STEM CELLS May 23, 2017 Abandoned
Array ( [id] => 12051500 [patent_doc_number] => 20170327844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-16 [patent_title] => 'OPTIMIZATION OF DETERMINANTS FOR SUCCESSFUL GENETIC CORRECTION OF DISEASES, MEDIATED BY HEMATOPOIETIC STEM CELLS' [patent_app_type] => utility [patent_app_number] => 15/603510 [patent_app_country] => US [patent_app_date] => 2017-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 51600 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15603510 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/603510
OPTIMIZATION OF DETERMINANTS FOR SUCCESSFUL GENETIC CORRECTION OF DISEASES, MEDIATED BY HEMATOPOIETIC STEM CELLS May 23, 2017 Abandoned
Array ( [id] => 14273769 [patent_doc_number] => 20190134169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-09 [patent_title] => DLL4-expressing cells and vaccine using the same [patent_app_type] => utility [patent_app_number] => 16/095986 [patent_app_country] => US [patent_app_date] => 2017-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28874 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095986 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/095986
DLL4-expressing cells and vaccine using the same Apr 25, 2017 Abandoned
Array ( [id] => 15681775 [patent_doc_number] => 20200095551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-26 [patent_title] => METHODS, SYSTEMS, FACTORS, AND MEDIA FOR REDUCTION OF CELLULAR STRESS AND REACTIVE OXYGEN SPECIES [patent_app_type] => utility [patent_app_number] => 16/494662 [patent_app_country] => US [patent_app_date] => 2017-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10392 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494662 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/494662
METHODS, SYSTEMS, FACTORS, AND MEDIA FOR REDUCTION OF CELLULAR STRESS AND REACTIVE OXYGEN SPECIES Mar 16, 2017 Abandoned
Array ( [id] => 13397697 [patent_doc_number] => 20180250391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-06 [patent_title] => COMPOSITIONS AND METHODS FOR INDUCING AND ENHANCING AN IMMUNE RESPONSE [patent_app_type] => utility [patent_app_number] => 15/760726 [patent_app_country] => US [patent_app_date] => 2016-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45915 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15760726 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/760726
COMPOSITIONS AND METHODS FOR INDUCING AND ENHANCING AN IMMUNE RESPONSE Sep 15, 2016 Abandoned
Array ( [id] => 15345925 [patent_doc_number] => 20200010854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-09 [patent_title] => CRISPR/CAS9-BASED TREATMENTS [patent_app_type] => utility [patent_app_number] => 15/741444 [patent_app_country] => US [patent_app_date] => 2016-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7392 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15741444 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/741444
CRISPR/CAS9-BASED TREATMENTS Jul 4, 2016 Abandoned
Array ( [id] => 10939431 [patent_doc_number] => 20140342452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-20 [patent_title] => 'Islet Cells From Human Embryonic Stem Cells' [patent_app_type] => utility [patent_app_number] => 14/315204 [patent_app_country] => US [patent_app_date] => 2014-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13736 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14315204 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/315204
Islet Cells From Human Embryonic Stem Cells Jun 24, 2014 Abandoned
Array ( [id] => 9383987 [patent_doc_number] => 20140087469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-27 [patent_title] => 'SYSTEM AND PROCESS FOR GENETIC AND EPIGENETIC TREATMENT' [patent_app_type] => utility [patent_app_number] => 14/096935 [patent_app_country] => US [patent_app_date] => 2013-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8707 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14096935 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/096935
SYSTEM AND PROCESS FOR GENETIC AND EPIGENETIC TREATMENT Dec 3, 2013 Abandoned
Array ( [id] => 9477258 [patent_doc_number] => 20140134721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-15 [patent_title] => 'Chondrocyte Precursors Derived From Human Embryonic Stem Cells' [patent_app_type] => utility [patent_app_number] => 14/015040 [patent_app_country] => US [patent_app_date] => 2013-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8002 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14015040 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/015040
Chondrocyte Precursors Derived From Human Embryonic Stem Cells Aug 29, 2013 Abandoned
Array ( [id] => 9093695 [patent_doc_number] => 20130273006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-17 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF CIRRHOSIS AND LIVER FIBROSIS' [patent_app_type] => utility [patent_app_number] => 13/888748 [patent_app_country] => US [patent_app_date] => 2013-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 67 [patent_figures_cnt] => 67 [patent_no_of_words] => 31206 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13888748 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/888748
METHODS AND COMPOSITIONS FOR THE TREATMENT OF CIRRHOSIS AND LIVER FIBROSIS May 6, 2013 Abandoned
Array ( [id] => 10298850 [patent_doc_number] => 20150183850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-02 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING AMYLOID DEPOSITS' [patent_app_type] => utility [patent_app_number] => 14/402064 [patent_app_country] => US [patent_app_date] => 2013-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 21880 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14402064 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/402064
METHODS AND COMPOSITIONS FOR TREATING AMYLOID DEPOSITS Mar 13, 2013 Abandoned
Array ( [id] => 10947066 [patent_doc_number] => 20140350087 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2014-11-27 [patent_title] => 'Oncovector Nucleic Acid Molecules and Methods of Use' [patent_app_type] => utility [patent_app_number] => 13/801940 [patent_app_country] => US [patent_app_date] => 2013-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 80619 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13801940 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/801940
Oncovector Nucleic Acid Molecules and Methods of Use Mar 12, 2013 Abandoned
Menu